Alto Ingredients (ALTO) 10-Q 9 May 23 2023 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2023	May 08, 2023
Document Information Line Items
Entity Registrant Name	Alto Ingredients, Inc.
Trading Symbol	ALTO
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		76,105,690
Amendment Flag	false
Entity Central Index Key	0000778164
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Document Period End Date	Mar. 31, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-21467
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	41-2170618
Entity Address, Address Line One	1300 South Second Street
Entity Address, City or Town	Pekin
Entity Address, State or Province	IL
Entity Address, Postal Zip Code	61554
City Area Code	(916)
Local Phone Number	403-2123
Title of 12(b) Security	Common Stock, $0.001 par value
Security Exchange Name	NASDAQ
Entity Interactive Data Current	Yes

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022	[1]
Current Assets:
Cash and cash equivalents	$ 21,173	$ 36,456
Restricted cash	5,263	13,069
Accounts receivable (net of allowance for credit losses of $66 and $105, respectively)	66,537	68,655
Inventories	67,147	66,628
Derivative instruments	6,267	4,973
Other current assets	5,217	9,340
Total current assets	171,604	199,121
Property and equipment, net	244,172	239,069
Other Assets:
Right of use operating lease assets, net	23,046	18,937
Intangible assets, net	8,940	9,087
Goodwill	5,970	5,970
Other assets	6,172	6,137
Total other assets	44,128	40,131
Total Assets	459,904	478,321
Current Liabilities:
Accounts payable	24,406	28,115
Accrued liabilities	17,334	26,556
Current portion – operating leases	3,856	3,849
Derivative instruments	2,100	6,732
Other current liabilities	6,150	12,765
Total current liabilities	53,846	78,017
Long-term debt	83,739	68,356
Operating leases, net of current portion	19,678	15,062
Other liabilities	8,966	8,797
Total Liabilities	166,229	170,232
Commitments and Contingencies (Note 6)
Stockholders’ Equity:
Preferred stock, $0.001 par value; 10,000 shares authorized; Series A: 1,684 shares authorized; no shares issued and outstanding as of March 31, 2023 and December 31, 2022; Series B: 1,581 shares authorized; 927 shares issued and outstanding as of March 31, 2023 and December 31, 2022; liquidation preference of $18,075 as of March 31, 2023	1	1
Common stock, value	76	75
Additional paid-in capital	1,039,897	1,040,834
Accumulated other comprehensive income	1,822	1,822
Accumulated deficit	(748,121)	(734,643)
Total Stockholders’ Equity	293,675	308,089
Total Liabilities and Stockholders’ Equity	459,904	478,321
Non-voting common stock
Stockholders’ Equity:
Common stock, value
[1] Amounts derived from the audited financial statements for the year ended December 31, 2022.

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - USD ($) shares in Thousands, $ in Thousands	Mar. 31, 2023	Dec. 31, 2022	[1]
Accounts receivable, net of allowance (in Dollars)	$ 66	$ 105
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000	10,000
Preferred stock, liquidation preference (in Dollars)	$ 18,075	$ 18,075
Common stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	300,000	300,000
Common stock, shares issued	76,187	75,154
Common stock, shares outstanding	76,187	75,154
Series A Preferred Stock
Preferred stock, shares authorized	1,684	1,684
Preferred stock, shares issued
Preferred stock, shares outstanding
Series B Preferred Stock
Preferred stock, shares authorized	1,581	1,581
Preferred stock, shares issued	927	927
Preferred stock, shares outstanding	927	927
Non-voting common stock
Common stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	3,553	3,553
Common stock, shares issued	1	1
Common stock, shares outstanding	1	1
[1] Amounts derived from the audited financial statements for the year ended December 31, 2022.

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Net sales	$ 313,891	$ 308,118
Cost of goods sold	317,055	303,345
Gross profit (loss)	(3,164)	4,773
Selling, general and administrative expenses	(7,882)	(7,629)
Asset impairments	(574)
Loss from operations	(11,620)	(2,856)
Interest expense, net	(1,565)	(200)
Other income, net	19	454
Loss before provision for income taxes	(13,166)	(2,602)
Provision for income taxes
Net loss	(13,166)	(2,602)
Preferred stock dividends	(312)	(312)
Net loss available to common stockholders	$ (13,478)	$ (2,914)
Net loss per share, basic and diluted (in Dollars per share)	$ (0.18)	$ (0.04)
Weighted-average shares outstanding, basic (in Shares)	73,815	71,390
Weighted-average shares outstanding, diluted (in Shares)	73,815	71,390

Consolidated Statements of Op_2

Consolidated Statements of Operations (Unaudited) (Parentheticals) - $ / shares	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Net loss per share, diluted	$ (0.18)	$ (0.04)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating Activities:
Net loss	$ (13,166)	$ (2,602)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization of intangibles	6,055	6,134
Losses (gains) on derivative instruments	1,777	(5,316)
Non-cash compensation	752	673
Asset impairments	574
Amortization of deferred financing fees	235	6
Amortization of debt discount	198
Bad debt expense (recovery)	(39)	31
Changes in operating assets and liabilities, net of business acquisition:
Accounts receivable	2,157	11,775
Inventories	(519)	(2,773)
Other assets	4,027	14,119
Operating leases	(1,226)	(1,257)
Accounts payable and accrued liabilities	(24,172)	(9,726)
Net cash provided by (used in) operating activities	(23,347)	11,064
Investing Activities:
Additions to property and equipment	(9,602)	(2,334)
Deferred purchase price payments for Eagle Alcohol	(3,500)
Purchase of Eagle Alcohol, net of cash acquired		(14,655)
Net cash used in investing activities	(13,102)	(16,989)
Financing Activities:
Net proceeds from Kinergy’s line of credit	15,354	3,314
Stock repurchases	(1,682)
Proceeds from principal payments on notes receivable		781
Preferred stock dividends paid	(312)	(312)
Net cash provided by financing activities	13,360	3,783
Net decrease in cash, cash equivalents and restricted cash	(23,089)	(2,142)
Cash, cash equivalents and restricted cash at beginning of period	49,525	62,125
Cash, cash equivalents and restricted cash at end of period	26,436	59,983
Reconciliation of total cash, cash equivalents and restricted cash:
Cash and cash equivalents	21,173	36,184
Restricted cash	5,263	23,799
Total cash, cash equivalents and restricted cash	26,436	59,983
Supplemental Information:
Interest paid	1,886	195
Interest expense capitalized	$ 839	$ 45

Consolidated Statements of Stoc

Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Preferred Stock	Common Stock and Non-Voting Common	Additional Paid-In Capital	Accumulated Deficit	Accum. Other Comprehensive Loss	Non- Controlling Interests
Balance at Dec. 31, 2021	$ 1	$ 73	$ 1,037,205	$ (691,781)	$ (284)	$ 345,214
Balance (in Shares) at Dec. 31, 2021	927	72,778
Stock-based compensation			673			673
Restricted stock issued to employees and directors, net of cancellations and tax			(9)			(9)
Restricted stock issued to employees and directors, net of cancellations and tax (in Shares)		684
Shares issued for Eagle Alcohol acquisition		$ 1				1
Shares issued for Eagle Alcohol acquisition (in Shares)		949
Preferred stock dividends				(312)		(312)
Net loss				(2,602)		(2,602)
Balance at Mar. 31, 2022	$ 1	$ 74	1,037,869	(694,695)	(284)	342,965
Balance (in Shares) at Mar. 31, 2022	927	74,411
Balance at Dec. 31, 2022	$ 1	$ 75	1,040,834	(734,643)	1,822	308,089
Balance (in Shares) at Dec. 31, 2022	927	75,154
Stock-based compensation			752			752
Restricted stock issued to employees and directors, net of cancellations and tax		$ 2	(8)			(6)
Restricted stock issued to employees and directors, net of cancellations and tax (in Shares)		1,893
Stock repurchases		$ (1)	(1,681)			(1,682)
Stock repurchases (in Shares)		(860)
Preferred stock dividends				(312)		(312)
Net loss				(13,166)		(13,166)
Balance at Mar. 31, 2023	$ 1	$ 76	$ 1,039,897	$ (748,121)	$ 1,822	$ 293,675
Balance (in Shares) at Mar. 31, 2023	927	76,187

Organization and Basis of Prese

Organization and Basis of Presentation	3 Months Ended
	Mar. 31, 2023
Organization and Basis of Presentation [Abstract]
ORGANIZATION AND BASIS OF PRESENTATION	1. ORGANIZATION Organization and Business The Company is a leading producer and distributor of specialty alcohols and essential ingredients. The Company also produces and markets fuel-grade ethanol. The Company’s production facilities in Pekin, Illinois are located in the heart of the Corn Belt. The Company’s two production facilities in Oregon and Idaho are located in close proximity to both feed and fuel-grade ethanol customers. The Company has a combined alcohol production capacity of 350 million gallons per year and produced in 2022 over 1.6 million tons of essential ingredients, such as dried yeast, corn gluten meal, corn gluten feed, corn germ, and distillers grains and liquid feed used in commercial animal feed and pet foods. In addition, the Company markets and distributes fuel-grade ethanol produced by third parties. The Company focuses on four key markets: Health, Home & Beauty Food & Beverage Essential Ingredients Renewable Fuels As of March 31, 2023, all of the Company’s production facilities were operating, except its Magic Valley facility in Idaho. On January 1, 2023, the Company temporarily hot-idled its Magic Valley production facility due to extreme natural gas prices, other unfavorable market conditions and to facilitate the installation of its new high protein systems. The Company restarted the facility in April 2023. All production facilities are currently operating. As market conditions change, the Company may increase, decrease or idle production at one or more operating facilities or resume operations at any idled facility. Basis of Presentation – Interim Financial Statements Accounts Receivable and Allowance for Credit Losses The carrying amount of accounts receivable is reduced by a valuation allowance that reflects the Company’s best estimate of the amounts that will not be collected. The Company regularly reviews accounts receivable and based on assessments of current customer creditworthiness, estimates the portion, if any, of the customer balance that will not be collected. Of the accounts receivable balance, approximately $53,655,000 and $55,667,000 at March 31, 2023 and December 31, 2022, respectively, were used as collateral under Kinergy’s operating line of credit. The allowance for credit losses was $66,000 and $105,000 as of March 31, 2023 and December 31, 2022, respectively. The Company recorded a bad debt recovery of $39,000 and bad debt expense of $31,000 for the three months ended March 31, 2023 and 2022, respectively. The Company does not have any off-balance sheet credit exposure related to its customers. Share Repurchase Program Financial Instruments Estimates and Assumptions

Segments

Segments	3 Months Ended
	Mar. 31, 2023
Segment Reporting [Abstract]
SEGMENTS	2. SEGMENTS. The Company reports its financial and operating performance in three segments: (1) marketing and distribution, which includes marketing and merchant trading for Company-produced alcohols and essential ingredients on an aggregated basis, and sales of fuel-grade ethanol sourced from third parties (2) Pekin production, which includes the production and sale of alcohols and essential ingredients produced at the Company’s Pekin, Illinois campus (“Pekin Campus”), and (3) Other production, which includes the production and sale of fuel-grade ethanol and essential ingredients produced at all of the Company’s other production facilities on an aggregated basis (“Other production”), none of which are individually so significant to be considered a separately reportable segment. The following tables set forth certain financial data for the Company’s operating segments (in thousands): Three Months Ended 2023 2022 Net Sales Pekin Campus production, recorded as gross: Alcohol sales $ 132,381 $ 116,050 Essential ingredient sales 63,631 55,280 Intersegment sales 313 256 Total Pekin Campus sales 196,325 171,586 Marketing and distribution: Alcohol sales, gross $ 84,381 $ 53,926 Alcohol sales, net 114 351 Intersegment sales 2,843 2,996 Total marketing and distribution sales 87,338 57,273 Other production, recorded as gross: Alcohol sales $ 20,932 $ 59,805 Essential ingredient sales 8,353 18,938 Intersegment sales 1 12 Total Other production sales 29,286 78,755 Corporate and other 4,099 3,768 Intersegment eliminations (3,157 ) (3,264 ) Net sales as reported $ 313,891 $ 308,118 Cost of goods sold: Pekin Campus production $ 198,178 $ 168,881 Marketing and distribution 83,126 54,716 Other production 33,982 78,244 Corporate and other 2,369 2,872 Intersegment eliminations (600 ) (1,368 ) Cost of goods sold as reported $ 317,055 $ 303,345 Gross profit (loss): Pekin Campus production $ (1,853 ) $ 2,705 Marketing and distribution 4,212 2,557 Other production (4,696 ) 511 Corporate and other 1,730 896 Intersegment eliminations (2,557 ) (1,896 ) Gross profit (loss) as reported $ (3,164 ) $ 4,773 Loss before provision for income taxes: Pekin Campus production $ (5,117 ) $ 85 Marketing and distribution 2,010 785 Other production (5,698 ) (1,209 ) Corporate and other (4,361 ) (2,263 ) $ (13,166 ) $ (2,602 ) Depreciation and amortization expense: Pekin Campus production $ 4,819 $ 4,538 Other production 1,009 1,456 Corporate and other 227 140 $ 6,055 $ 6,134 Interest expense, net of capitalized interest: Pekin Campus production $ (485 ) $ — Marketing and distribution 494 200 Other production (354 ) — Corporate and other 1,910 — $ 1,565 $ 200 The following table sets forth the Company’s total assets by operating segment (in thousands): March 31, December 31, Total assets: Pekin Campus production $ 254,293 $ 257,089 Marketing and distribution 116,135 114,755 Other production 46,832 51,886 Corporate and other 42,644 54,591 $ 459,904 $ 478,321

Inventories

Inventories	3 Months Ended
	Mar. 31, 2023
Inventory Disclosure [Abstract]
INVENTORIES	3. INVENTORIES. Inventories consisted primarily of bulk ethanol, specialty alcohols, corn, essential ingredients and unleaded fuel, and are valued at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Inventory is net of a valuation adjustment of $0 and $4,612,000 as of March 31, 2023 and December 31, 2022, respectively. Inventory balances consisted of the following (in thousands): March 31, December 31, Finished goods $ 44,309 $ 47,736 Work in progress 5,321 6,396 Raw materials 16,055 11,197 Other 1,462 1,299 Total $ 67,147 $ 66,628

Derivatives

Derivatives	3 Months Ended
	Mar. 31, 2023
Derivatives [Abstract]
DERIVATIVES	4. DERIVATIVES. The business and activities of the Company expose it to a variety of market risks, including risks related to changes in commodity prices. The Company monitors and manages these financial exposures as an integral part of its risk management program. This program recognizes the unpredictability of financial markets and seeks to reduce the potentially adverse effects that market volatility could have on operating results. Commodity Risk – Cash Flow Hedges Commodity Risk – Non-Designated Hedges Non Designated Derivative Instruments As of March 31, 2023 Assets Liabilities Type of Instrument Balance Sheet Location Fair Value Balance Sheet Location Fair Value Cash collateral balance Restricted cash $ 5,263 Commodity contracts Derivative instruments $ 6,267 Derivative instruments $ 2,100 As of December 31, 2022 Assets Liabilities Type of Instrument Balance Sheet Location Fair Value Balance Sheet Location Fair Value Cash collateral balance Restricted cash $ 13,069 Commodity contracts Derivative instruments $ 4,973 Derivative instruments $ 6,732 The above amounts represent the gross balances of the contracts; however, the Company does have a right of offset with each of its derivative brokers, but the Company’s intent is to close out positions individually, therefore the positions are reported at gross. The classification and amounts of the Company’s realized gains (losses) for its derivatives not designated as hedging instruments are as follows (in thousands): Realized Gains (Losses) For the three months Ended Type of Instrument Statements of Operations Location 2023 2022 Commodity contracts Cost of goods sold $ (7,703 ) $ 15,562 $ (7,703 ) $ 15,562 Unrealized Gains (Losses) For the three months Ended March 31, Type of Instrument Statements of Operations Location 2023 2022 Commodity contracts Cost of goods sold $ 5,926 $ (10,246 ) $ 5,926 $ (10,246 )

Debt

Debt	3 Months Ended
	Mar. 31, 2023
Debt [Abstract]
DEBT	5. DEBT. Long-term borrowings are summarized as follows (in thousands): March 31, December 31, Kinergy line of credit $ 33,430 $ 18,076 Orion term loan 60,000 60,000 93,430 78,076 Less unamortized debt discount (4,497 ) (4,686 ) Less unamortized debt financing costs (5,194 ) (5,034 ) Less current portion — — Long-term debt $ 83,739 $ 68,356 Excess Availability

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	6. COMMITMENTS AND CONTINGENCIES. Sales Commitments Purchase Commitments Litigation – General

Pension Plans

Pension Plans	3 Months Ended
	Mar. 31, 2023
Pension Plans [Abstract]
PENSION PLANS	7. PENSION PLANS. The Company sponsors a defined benefit pension plan (the “Retirement Plan”) and a healthcare and life insurance plan (the “Postretirement Plan”). The Retirement Plan is noncontributory and covers only “grandfathered” unionized employees at the Company’s Pekin, Illinois facility who fulfill minimum age and service requirements. Benefits are based on a prescribed formula based upon the employee’s years of service. The Retirement Plan, which is part of a collective bargaining agreement, covers only union employees hired prior to November 1, 2010. The Company uses a December 31 measurement date for its Retirement Plan. The Company’s funding policy is to make the minimum annual contribution required by applicable regulations. As of December 31, 2022, the Retirement Plan’s accumulated projected benefit obligation was $18.0 million, with a fair value of plan assets of $16.7 million. The underfunded amount of $1.3 million is recorded on the Company’s consolidated balance sheet in other liabilities. For the three months ended March 31, 2023, the Retirement Plan’s net periodic expense was $39,000, comprised of $225,000 in interest cost and $62,000 in service cost, partially offset by $248,000 of expected return on plan assets. For the three months ended March 31, 2022, the Retirement Plan’s net periodic expense (income) was ($8,000), comprised of $164,000 in interest cost and $101,000 in service cost, more than offset by $273,000 of expected return on plan assets. The Postretirement Plan provides postretirement medical benefits and life insurance to certain “grandfathered” unionized employees at the Company’s Pekin, Illinois facility. Employees hired after December 31, 2000 are not eligible to participate in the Postretirement Plan. The Postretirement Plan is contributory, with contributions required at the same rate as active employees. Benefit eligibility under the plan reduces at age 65 from a defined benefit to a defined dollar cap based upon years of service. As of December 31, 2022, the Postretirement Plan’s accumulated projected benefit obligation was $3.9 million and is recorded on the Company’s consolidated balance sheet in other liabilities. The Company’s funding policy is to make the minimum annual contribution required by applicable regulations. For the three months ended March 31, 2023, the Postretirement Plan’s net periodic expense was $36,000, comprised of $46,000 of interest cost and $3,000 of service cost, partially offset by $13,000 in amortization of gains. For the three months ended March 31, 2022, the Postretirement Plan’s net periodic expense was $32,000, comprised of $26,000 of interest cost and $6,000 of service cost.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2023
Fair Value Measurements [Abstract]
FAIR VALUE MEASUREMENTS	8. FAIR VALUE MEASUREMENTS. The fair value hierarchy prioritizes the inputs used in valuation techniques into three levels, as follows: ● Level 1 – Observable inputs – unadjusted quoted prices in active markets for identical assets and liabilities; ● Level 2 – Observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability through corroboration with market data; and ● Level 3 – Unobservable inputs – includes amounts derived from valuation models where one or more significant inputs are unobservable. For fair value measurements using significant unobservable inputs, a description of the inputs and the information used to develop the inputs is required along with a reconciliation of Level 3 values from the prior reporting period. Pooled separate accounts Other Derivative Instruments The following table summarizes recurring and nonrecurring fair value measurements by level at March 31, 2023 (in thousands): Fair Value Level 1 Level 2 Level 3 Assets: Derivative financial instruments $ 6,267 $ 6,267 $ — $ — Liabilities: Derivative financial instruments $ (2,100 ) $ (2,100 ) $ — $ — The following table summarizes recurring and nonrecurring fair value measurements by level at December 31, 2022 (in thousands): Benefit Plan Fair Percentage Value Level 1 Level 2 Level 3 Allocation Assets: Derivative financial instruments $ 4,973 $ 4,973 $ — $ — Defined benefit plan assets(1) (pooled separate accounts): Large U.S. Equity(2) 4,586 — 4,586 — 28 % Small/Mid U.S. Equity(3) 2,986 — 2,986 — 18 % International Equity(4) 2,406 — 2,406 — 14 % Fixed Income(5) 6,710 — 6,710 — 40 % $ 21,661 $ 4,973 $ 16,688 $ — Liabilities: Derivative financial instruments $ 6,732 $ 6,732 $ — $ — (1) Included in other assets in the consolidated balance sheets. (2) This category includes investments in funds comprised of equity securities of large U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund. (3) This category includes investments in funds comprised of equity securities of small- and medium-sized U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund. (4) This category includes investments in funds comprised of equity securities of foreign companies including emerging markets. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund. (5) This category includes investments in funds comprised of U.S. and foreign investment-grade fixed income securities, high-yield fixed income securities that are rated below investment-grade, U.S. treasury securities, mortgage-backed securities, and other asset-backed securities. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

Earnings Per Share

Earnings Per Share	3 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
EARNINGS PER SHARE	9. EARNINGS PER SHARE. The following tables compute basic and diluted earnings per share (in thousands, except per share data): Three Months Ended Loss Shares Per-Share Net loss $ (13,166 ) Less: Preferred stock dividends (312 ) Basic and diluted loss per share: Net loss available to common stockholders $ (13,478 ) 73,815 $ (0.18 ) Three Months Ended Loss Shares Per-Share Net loss $ (2,602 ) Less: Preferred stock dividends (312 ) Basic and diluted loss per share: Net loss available to common stockholders $ (2,914 ) 71,390 $ (0.04 ) There were an additional aggregate potentially dilutive weighted-average shares of 964,000 and 1,339,000 from convertible securities outstanding for the three months ended March 31, 2023 and 2022. These securities were not considered in calculating diluted net loss per share for the three months ended March 31, 2023 and 2022, as their effect would have been anti-dilutive.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	3 Months Ended
	Mar. 31, 2023
Organization and Basis of Presentation [Abstract]
Organization and Business	Organization and Business The Company is a leading producer and distributor of specialty alcohols and essential ingredients. The Company also produces and markets fuel-grade ethanol. The Company’s production facilities in Pekin, Illinois are located in the heart of the Corn Belt. The Company’s two production facilities in Oregon and Idaho are located in close proximity to both feed and fuel-grade ethanol customers. The Company has a combined alcohol production capacity of 350 million gallons per year and produced in 2022 over 1.6 million tons of essential ingredients, such as dried yeast, corn gluten meal, corn gluten feed, corn germ, and distillers grains and liquid feed used in commercial animal feed and pet foods. In addition, the Company markets and distributes fuel-grade ethanol produced by third parties. The Company focuses on four key markets: Health, Home & Beauty Food & Beverage Essential Ingredients Renewable Fuels As of March 31, 2023, all of the Company’s production facilities were operating, except its Magic Valley facility in Idaho. On January 1, 2023, the Company temporarily hot-idled its Magic Valley production facility due to extreme natural gas prices, other unfavorable market conditions and to facilitate the installation of its new high protein systems. The Company restarted the facility in April 2023. All production facilities are currently operating. As market conditions change, the Company may increase, decrease or idle production at one or more operating facilities or resume operations at any idled facility.
Basis of Presentation–Interim Financial Statements	Basis of Presentation – Interim Financial Statements
Accounts Receivable and Allowance for Credit Losses	Accounts Receivable and Allowance for Credit Losses The carrying amount of accounts receivable is reduced by a valuation allowance that reflects the Company’s best estimate of the amounts that will not be collected. The Company regularly reviews accounts receivable and based on assessments of current customer creditworthiness, estimates the portion, if any, of the customer balance that will not be collected. Of the accounts receivable balance, approximately $53,655,000 and $55,667,000 at March 31, 2023 and December 31, 2022, respectively, were used as collateral under Kinergy’s operating line of credit. The allowance for credit losses was $66,000 and $105,000 as of March 31, 2023 and December 31, 2022, respectively. The Company recorded a bad debt recovery of $39,000 and bad debt expense of $31,000 for the three months ended March 31, 2023 and 2022, respectively. The Company does not have any off-balance sheet credit exposure related to its customers.
Share Repurchase Program	Share Repurchase Program
Financial Instruments	Financial Instruments
Estimates and Assumptions	Estimates and Assumptions

Segments (Tables)

Segments (Tables)	3 Months Ended
	Mar. 31, 2023
Segment Reporting [Abstract]
Schedule of financial data for operating segments	Three Months Ended 2023 2022 Net Sales Pekin Campus production, recorded as gross: Alcohol sales $ 132,381 $ 116,050 Essential ingredient sales 63,631 55,280 Intersegment sales 313 256 Total Pekin Campus sales 196,325 171,586 Marketing and distribution: Alcohol sales, gross $ 84,381 $ 53,926 Alcohol sales, net 114 351 Intersegment sales 2,843 2,996 Total marketing and distribution sales 87,338 57,273 Other production, recorded as gross: Alcohol sales $ 20,932 $ 59,805 Essential ingredient sales 8,353 18,938 Intersegment sales 1 12 Total Other production sales 29,286 78,755 Corporate and other 4,099 3,768 Intersegment eliminations (3,157 ) (3,264 ) Net sales as reported $ 313,891 $ 308,118 Cost of goods sold: Pekin Campus production $ 198,178 $ 168,881 Marketing and distribution 83,126 54,716 Other production 33,982 78,244 Corporate and other 2,369 2,872 Intersegment eliminations (600 ) (1,368 ) Cost of goods sold as reported $ 317,055 $ 303,345 Gross profit (loss): Pekin Campus production $ (1,853 ) $ 2,705 Marketing and distribution 4,212 2,557 Other production (4,696 ) 511 Corporate and other 1,730 896 Intersegment eliminations (2,557 ) (1,896 ) Gross profit (loss) as reported $ (3,164 ) $ 4,773 Loss before provision for income taxes: Pekin Campus production $ (5,117 ) $ 85 Marketing and distribution 2,010 785 Other production (5,698 ) (1,209 ) Corporate and other (4,361 ) (2,263 ) $ (13,166 ) $ (2,602 ) Depreciation and amortization expense: Pekin Campus production $ 4,819 $ 4,538 Other production 1,009 1,456 Corporate and other 227 140 $ 6,055 $ 6,134 Interest expense, net of capitalized interest: Pekin Campus production $ (485 ) $ — Marketing and distribution 494 200 Other production (354 ) — Corporate and other 1,910 — $ 1,565 $ 200
Schedule of assets by operating segments	March 31, December 31, Total assets: Pekin Campus production $ 254,293 $ 257,089 Marketing and distribution 116,135 114,755 Other production 46,832 51,886 Corporate and other 42,644 54,591 $ 459,904 $ 478,321

Inventories (Tables)

Inventories (Tables)	3 Months Ended
	Mar. 31, 2023
Inventory Disclosure [Abstract]
Schedule of inventories	March 31, December 31, Finished goods $ 44,309 $ 47,736 Work in progress 5,321 6,396 Raw materials 16,055 11,197 Other 1,462 1,299 Total $ 67,147 $ 66,628

Derivatives (Tables)

Derivatives (Tables)	3 Months Ended
	Mar. 31, 2023
Derivatives [Abstract]
Schedule of derivatives not designated as hedging instruments	As of March 31, 2023 Assets Liabilities Type of Instrument Balance Sheet Location Fair Value Balance Sheet Location Fair Value Cash collateral balance Restricted cash $ 5,263 Commodity contracts Derivative instruments $ 6,267 Derivative instruments $ 2,100 As of December 31, 2022 Assets Liabilities Type of Instrument Balance Sheet Location Fair Value Balance Sheet Location Fair Value Cash collateral balance Restricted cash $ 13,069 Commodity contracts Derivative instruments $ 4,973 Derivative instruments $ 6,732
Schedule of recognized gains (losses) for its derivatives	Realized Gains (Losses) For the three months Ended Type of Instrument Statements of Operations Location 2023 2022 Commodity contracts Cost of goods sold $ (7,703 ) $ 15,562 $ (7,703 ) $ 15,562 Unrealized Gains (Losses) For the three months Ended March 31, Type of Instrument Statements of Operations Location 2023 2022 Commodity contracts Cost of goods sold $ 5,926 $ (10,246 ) $ 5,926 $ (10,246 )

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2023
Debt [Abstract]
Schedule of long-term borrowings	March 31, December 31, Kinergy line of credit $ 33,430 $ 18,076 Orion term loan 60,000 60,000 93,430 78,076 Less unamortized debt discount (4,497 ) (4,686 ) Less unamortized debt financing costs (5,194 ) (5,034 ) Less current portion — — Long-term debt $ 83,739 $ 68,356

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2023
Fair Value Measurements [Abstract]
Schedule of recurring and nonrecurring fair value measurements	Fair Value Level 1 Level 2 Level 3 Assets: Derivative financial instruments $ 6,267 $ 6,267 $ — $ — Liabilities: Derivative financial instruments $ (2,100 ) $ (2,100 ) $ — $ — Benefit Plan Fair Percentage Value Level 1 Level 2 Level 3 Allocation Assets: Derivative financial instruments $ 4,973 $ 4,973 $ — $ — Defined benefit plan assets(1) (pooled separate accounts): Large U.S. Equity(2) 4,586 — 4,586 — 28 % Small/Mid U.S. Equity(3) 2,986 — 2,986 — 18 % International Equity(4) 2,406 — 2,406 — 14 % Fixed Income(5) 6,710 — 6,710 — 40 % $ 21,661 $ 4,973 $ 16,688 $ — Liabilities: Derivative financial instruments $ 6,732 $ 6,732 $ — $ — (1) Included in other assets in the consolidated balance sheets. (2) This category includes investments in funds comprised of equity securities of large U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund. (3) This category includes investments in funds comprised of equity securities of small- and medium-sized U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund. (4) This category includes investments in funds comprised of equity securities of foreign companies including emerging markets. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund. (5) This category includes investments in funds comprised of U.S. and foreign investment-grade fixed income securities, high-yield fixed income securities that are rated below investment-grade, U.S. treasury securities, mortgage-backed securities, and other asset-backed securities. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

Earnings Per Share (Tables)

Earnings Per Share (Tables)	3 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
Schedule of basic and diluted earnings per share	Three Months Ended Loss Shares Per-Share Net loss $ (13,166 ) Less: Preferred stock dividends (312 ) Basic and diluted loss per share: Net loss available to common stockholders $ (13,478 ) 73,815 $ (0.18 ) Three Months Ended Loss Shares Per-Share Net loss $ (2,602 ) Less: Preferred stock dividends (312 ) Basic and diluted loss per share: Net loss available to common stockholders $ (2,914 ) 71,390 $ (0.04 )

Organization and Basis of Pre_2

Organization and Basis of Presentation (Details) - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		12 Months Ended
	Sep. 12, 2022	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Organization and Basis of Presentation [Abstract]
Production capacity per year		$ 350,000
Annual payments of essential ingredients		1,600
Accounts receivable		53,655,000		$ 55,667,000
Allowance for credit losses		66,000		$ 105,000
Bad debt recovery		39,000
Bad debt expenses		31,000	$ 31,000
Repurchase of common stock	$ 50,000
Excess amount of initial purchase	$ 10,000
Authorized value		5,000
Additional lender value		5,000
Purchase additional amount		$ 10,000
Repurchased aggregate shares (in Shares)		860,000
Repurchased an aggregate shares in cash		$ 1,682,000
Total repurchase amount		$ 3,007,000

Segments (Details) - Schedule o

Segments (Details) - Schedule of financial data for operating segments - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cost of goods sold:
Cost of goods sold	$ 317,055	$ 303,345
Gross profit (loss):
Gross profit (loss)	(3,164)	4,773
Loss before provision for income taxes:
Loss before provision for income taxes	(13,166)	(2,602)
Depreciation and amortization expense:
Depreciation and amortization expense	6,055	6,134
Interest expense, net of capitalized interest:
Interest expense, net of capitalized interest	1,565	200
Pekin Campus production [Member]
Interest expense, net of capitalized interest:
Interest expense, net of capitalized interest	(485)
Marketing and distribution [Member]
Cost of goods sold:
Cost of goods sold	83,126	54,716
Gross profit (loss):
Gross profit (loss)	4,212	2,557
Loss before provision for income taxes:
Loss before provision for income taxes	2,010	785
Interest expense, net of capitalized interest:
Interest expense, net of capitalized interest	494	200
Other production [Member]
Cost of goods sold:
Cost of goods sold	33,982	78,244
Gross profit (loss):
Gross profit (loss)	(4,696)	511
Loss before provision for income taxes:
Loss before provision for income taxes	(5,698)	(1,209)
Depreciation and amortization expense:
Depreciation and amortization expense	1,009	1,456
Interest expense, net of capitalized interest:
Interest expense, net of capitalized interest	(354)
Corporate and other [Member]
Net Sales
Net Sales	4,099	3,768
Loss before provision for income taxes:
Loss before provision for income taxes	(4,361)	(2,263)
Depreciation and amortization expense:
Depreciation and amortization expense	227	140
Interest expense, net of capitalized interest:
Interest expense, net of capitalized interest	1,910
Intersegment eliminations [Member]
Net Sales
Net Sales	(3,157)	(3,264)
Cost of goods sold:
Cost of goods sold	(600)	(1,368)
Gross profit (loss):
Gross profit (loss)	(2,557)	(1,896)
Pekin Campus production [Member]
Cost of goods sold:
Cost of goods sold	198,178	168,881
Gross profit (loss):
Gross profit (loss)	(1,853)	2,705
Loss before provision for income taxes:
Loss before provision for income taxes	(5,117)	85
Depreciation and amortization expense:
Depreciation and amortization expense	4,819	4,538
Corporate and other [Member]
Cost of goods sold:
Cost of goods sold	2,369	2,872
Gross profit (loss):
Gross profit (loss)	1,730	896
Gross profit (loss) as reported [Member]
Gross profit (loss):
Gross profit (loss)	(3,164)	4,773
Net sales as reported [Member]
Net Sales
Net Sales	313,891	308,118
Cost of goods sold as reported [Member]
Cost of goods sold:
Cost of goods sold	317,055	303,345
Alcohol sales [Member] | Pekin Campus production [Member]
Net Sales
Net Sales	132,381	116,050
Alcohol sales [Member] | Other production [Member]
Net Sales
Net Sales	20,932	59,805
Essential ingredient sales [Member] | Pekin Campus production [Member]
Net Sales
Net Sales	63,631	55,280
Essential ingredient sales [Member] | Other production [Member]
Net Sales
Net Sales	8,353	18,938
Intersegment sales [Member] | Pekin Campus production [Member]
Net Sales
Net Sales	313	256
Intersegment sales [Member] | Marketing and distribution [Member]
Net Sales
Net Sales	2,843	2,996
Intersegment sales [Member] | Other production [Member]
Net Sales
Net Sales	1	12
Total Pekin Campus sales [Member] | Pekin Campus production [Member]
Net Sales
Net Sales	196,325	171,586
Alcohol sales, gross [Member] | Marketing and distribution [Member]
Net Sales
Net Sales	84,381	53,926
Alcohol sales, net [Member] | Marketing and distribution [Member]
Net Sales
Net Sales	114	351
Total marketing and distribution sales [Member] | Marketing and distribution [Member]
Net Sales
Net Sales	87,338	57,273
Total Other production sales [Member] | Other production [Member]
Net Sales
Net Sales	$ 29,286	$ 78,755

Segments (Details) - Schedule_2

Segments (Details) - Schedule of assets by operating segments - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Total assets:
Total assets	$ 459,904	$ 478,321	[1]
Pekin Campus production [Member]
Total assets:
Total assets	254,293	257,089
Marketing and distribution [Member]
Total assets:
Total assets	116,135	114,755
Other production [Member]
Total assets:
Total assets	46,832	51,886
Corporate and other [Member]
Total assets:
Total assets	$ 42,644	$ 54,591
[1] Amounts derived from the audited financial statements for the year ended December 31, 2022.

Inventories (Details)

Inventories (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Inventory Disclosure [Abstract]
Inventory net	$ 0	$ 4,612,000

Inventories (Details) - Schedul

Inventories (Details) - Schedule of inventories - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Schedule of inventories [Abstract]
Finished goods	$ 44,309	$ 47,736
Work in progress	5,321	6,396
Raw materials	16,055	11,197
Other	1,462	1,299
Total	$ 67,147	$ 66,628

Derivatives (Details)

Derivatives (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Derivatives [Abstract]
Recognized net losses	$ 1,777,000	$ 5,316,000

Derivatives (Details) - Schedul

Derivatives (Details) - Schedule of derivatives not designated as hedging instruments - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Schedule of Derivatives not Designated as Hedging Instruments [Abstract]
Type of Instrument Cash collateral balance	Cash collateral balance	Cash collateral balance
Assets, Balance Sheet Location Cash collateral balance	Restricted cash	Restricted cash
Assets, Fair Value Cash collateral balance	$ 5,263	$ 13,069
Liabilities, Balance Sheet Location Cash collateral balance
Liabilities, Fair Value Cash collateral balance
Type of Instrument Commodity contracts	Commodity contracts	Commodity contracts
Assets, Balance Sheet Location Commodity contracts	Derivative instruments	Derivative instruments
Assets, Fair Value Commodity contracts	$ 6,267	$ 4,973
Liabilities, Balance Sheet Location Commodity contracts	Derivative instruments	Derivative instruments
Liabilities, Fair Value Commodity contracts	$ 2,100	$ 6,732

Derivatives (Details) - Sched_2

Derivatives (Details) - Schedule of recognized gains (losses) for its derivatives - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Realized Gains (Losses) [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Type of Instrument	Commodity contracts
Statements of Operations Location	Cost of goods sold
Realized Gains	$ (7,703)	$ 15,562
Total Realized Gains (Losses)	$ (7,703)	15,562
Unrealized Gains (Losses) [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Type of Instrument	Commodity contracts
Statements of Operations Location	Cost of goods sold
Realized Gains	$ 5,926	(10,246)
Total Unrealized Gains (Losses)	$ 5,926	$ (10,246)

Debt (Details)

Debt (Details) $ in Millions	Mar. 31, 2023 USD ($)
Debt [Abstract]
Unused borrowing	$ 41.6

Debt (Details) - Schedule of lo

Debt (Details) - Schedule of long-term borrowings - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Debt (Details) - Schedule of long-term borrowings [Line Items]
Term debt	$ 93,430	$ 78,076
Less unamortized debt discount	(4,497)	(4,686)
Less unamortized debt financing costs	(5,194)	(5,034)
Less current portion
Long-term debt	83,739	68,356
Kinergy line of credit [Member]
Debt (Details) - Schedule of long-term borrowings [Line Items]
Term debt	33,430	18,076
Orion term loan [Member]
Debt (Details) - Schedule of long-term borrowings [Line Items]
Term debt	$ 60,000	$ 60,000

Commitments and Contingencies (

Commitments and Contingencies (Details)	3 Months Ended
	Mar. 31, 2023 USD ($)
Commitments and Contingencies (Details) [Line Items]
Indexed price sales contracts gallons	128,000
Open fixed-price sales contracts valued	$ 13,652,000
Future commitments for capital projects	$ 21,730,000
Sales Commitments [Member]
Commitments and Contingencies (Details) [Line Items]
Indexed price sales contracts gallons	89,084,000
Alcohol From Suppliers [Member] | Purchase Commitments [Member]
Commitments and Contingencies (Details) [Line Items]
Indexed price sales contracts gallons	21,049,000
Fixed-price purchase contracts value	$ 612,000
Corn From Suppliers [Member] | Purchase Commitments [Member]
Commitments and Contingencies (Details) [Line Items]
Fixed-price purchase contracts value	$ 73,170,000
Natural Gas [Member] | Purchase Commitments [Member]
Commitments and Contingencies (Details) [Line Items]
Indexed price sales contracts gallons	487,000
Alcohol Sales Contracts [Member]
Commitments and Contingencies (Details) [Line Items]
Open fixed-price sales contracts valued	$ 110,251,000

Pension Plans (Details)

Pension Plans (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Pension Plan [Member]
Pension Plans (Details) [Line Items]
Projected benefit obligation, amount			$ 18,000
Fair value of plan assets			16,700
Underfunded amount			1,300
Net periodic expense	$ 39,000	$ (8,000)
Interest cost	225,000	164,000
Service cost	62,000	101,000
Expected return on plan assets	248,000	273,000
Postretirement Life Insurance [Member]
Pension Plans (Details) [Line Items]
Projected benefit obligation, amount			$ 3,900
Net periodic expense	36,000	32,000
Interest cost	46,000	26,000
Service cost	3,000	$ 6,000
Amortization of gains	$ 13,000

Fair Value Measurements (Detail

Fair Value Measurements (Details) - Schedule of recurring and nonrecurring fair value measurements - USD ($) $ in Thousands		Mar. 31, 2023	Dec. 31, 2022
Assets:
Asset			$ 21,661
Derivative Financial Instruments, Assets [Member]
Assets:
Asset		$ 6,267	4,973
Liabilities:
Liabilities		(2,100)
Large U.S. Equity [Member]
Assets:
Asset	[1],[2]		$ 4,586
Benefit Plan Percentage Allocation	[1],[2]		28%
Small/Mid U.S. Equity [Member]
Assets:
Asset	[1],[3]		$ 2,986
Benefit Plan Percentage Allocation	[1],[3]		18%
International Equity [Member]
Assets:
Asset	[1],[4]		$ 2,406
Benefit Plan Percentage Allocation	[1],[4]		14%
Fixed Income [Member]
Assets:
Asset	[1],[5]		$ 6,710
Benefit Plan Percentage Allocation	[1],[5]		40%
Derivative Financial Instruments, Liabilities [Member]
Liabilities:
Liabilities			$ 6,732
Level 1 [Member]
Assets:
Asset			4,973
Level 1 [Member] | Derivative Financial Instruments, Assets [Member]
Assets:
Asset		6,267	4,973
Liabilities:
Liabilities		(2,100)
Level 1 [Member] | Large U.S. Equity [Member]
Assets:
Asset	[1],[2]
Level 1 [Member] | Small/Mid U.S. Equity [Member]
Assets:
Asset	[1],[3]
Level 1 [Member] | International Equity [Member]
Assets:
Asset	[1],[4]
Level 1 [Member] | Fixed Income [Member]
Assets:
Asset	[1],[5]
Level 1 [Member] | Derivative Financial Instruments, Liabilities [Member]
Liabilities:
Liabilities			6,732
Level 2 [Member]
Assets:
Asset			16,688
Level 2 [Member] | Derivative Financial Instruments, Assets [Member]
Assets:
Asset
Liabilities:
Liabilities
Level 2 [Member] | Large U.S. Equity [Member]
Assets:
Asset	[1],[2]		4,586
Level 2 [Member] | Small/Mid U.S. Equity [Member]
Assets:
Asset	[1],[3]		2,986
Level 2 [Member] | International Equity [Member]
Assets:
Asset	[1],[4]		2,406
Level 2 [Member] | Fixed Income [Member]
Assets:
Asset	[1],[5]		6,710
Level 2 [Member] | Derivative Financial Instruments, Liabilities [Member]
Liabilities:
Liabilities
Level 3 [Member]
Assets:
Asset
Level 3 [Member] | Derivative Financial Instruments, Assets [Member]
Assets:
Asset
Liabilities:
Liabilities
Level 3 [Member] | Large U.S. Equity [Member]
Assets:
Asset	[1],[2]
Level 3 [Member] | Small/Mid U.S. Equity [Member]
Assets:
Asset	[1],[3]
Level 3 [Member] | International Equity [Member]
Assets:
Asset	[1],[4]
Level 3 [Member] | Fixed Income [Member]
Assets:
Asset	[1],[5]
Level 3 [Member] | Derivative Financial Instruments, Liabilities [Member]
Liabilities:
Liabilities
[1]Included in other assets in the consolidated balance sheets.[2]This category includes investments in funds comprised of equity securities of large U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.[3]This category includes investments in funds comprised of equity securities of small- and medium-sized U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.[4]This category includes investments in funds comprised of equity securities of foreign companies including emerging markets. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.[5]This category includes investments in funds comprised of U.S. and foreign investment-grade fixed income securities, high-yield fixed income securities that are rated below investment-grade, U.S. treasury securities, mortgage-backed securities, and other asset-backed securities. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

Earnings Per Share (Details)

Earnings Per Share (Details) - shares	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Earnings Per Share [Abstract]
Potentially dilutive shares from convertible securities outstanding	964,000	1,339,000

Earnings Per Share (Details) -

Earnings Per Share (Details) - Schedule of basic and diluted earnings per share - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Schedule of basic and diluted earnings per share [Abstract]
Net loss, Loss Numerator	$ (13,166)	$ (2,602)
Less: Preferred stock dividends, Loss Numerator	$ (312)	$ (312)
Less: Preferred stock dividends, Shares Denominator (in Shares)
Less: Preferred stock dividends, Per-Share Amount (in Dollars per share)
Basic and diluted loss per share:
Net loss available to common stockholders, Loss Numerator	$ (13,478)	$ (2,914)
Net loss available to common stockholders, Shares Denominator (in Shares)	73,815	71,390
Net loss available to common stockholders, Per-Share Amount (in Dollars per share)	$ (0.18)	$ (0.04)